Shire logo

SHP - Shire News Story

4690p 0.0  0.0%

Last Trade - 04/01/19

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £12.34bn
Position in Universe th / 1807

Director/PDMR Shareholding

Thu 1st November, 2018 4:15pm
Director/PDMR Shareholding

Director/PDMR Shareholding

November 1, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG)

Notification of transactions by persons discharging managerial responsibilities


1.
Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”)
a)NameFlemming Ornskov
2.Reason for the notification
a)Position / statusChief Executive Officer - PDMR
b)Initial notification / amendmentInitial notification
3.Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor
a)NameShire plc
b)LEI54930005LQRLI2UXRQ59
4.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrumentShire plc American Depositary Shares (“ADSs”)
Identification codeISIN: US82481R1068
b)Nature of the transactionAutomatic exercise of option over notional ADSs granted under the Shire Global Employee Stock Purchase Plan on November 1, 2017, and consequent receipt of ADSs.
c)Price(s) and volume(s)Price(s)Volume(s)
$125.4999
d)Aggregated information

- Aggregated volume

- Price
N/A (single transaction)
e)Date of the transactionOctober 31, 2018
f)Place of the transactionN/A


1.Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”)
a)NameJoanne Cordeiro
2.Reason for the notification
a)Position / statusChief Human Resources Officer - PDMR
b)Initial notification / amendmentInitial notification
3.Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor
a)NameShire plc
b)LEI54930005LQRLI2UXRQ59
4.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrumentShire plc American Depositary Shares (“ADSs”)
Identification codeISIN: US82481R1068
b)Nature of the transactionAutomatic exercise of option over notional ADSs granted under the Shire Global Employee Stock Purchase Plan on November 1, 2017, and consequent receipt of ADSs.
c)Price(s) and volume(s)Price(s)Volume(s)
$125.4999
d)Aggregated information

- Aggregated volume

- Price
N/A (single transaction)
e)Date of the transactionOctober 31, 2018
f)Place of the transactionN/A


1.Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”)
a)NameBill Mordan
2.Reason for the notification
a)Position / statusGeneral Counsel and Company Secretary - PDMR
b)Initial notification / amendmentInitial notification
3.Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor
a)NameShire plc
b)LEI54930005LQRLI2UXRQ59
4.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrumentShire plc American Depositary Shares (“ADSs”)
Identification codeISIN: US82481R1068
b)Nature of the transactionAutomatic exercise of option over notional ADSs granted under the Shire Global Employee Stock Purchase Plan on November 1, 2017, and consequent receipt of ADSs.
c)Price(s) and volume(s)Price(s)Volume(s)
$125.4999
d)Aggregated information

- Aggregated volume

- Price
N/A (single transaction)
e)Date of the transactionOctober 31, 2018
f)Place of the transactionN/A


1.Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”)
a)NamePerry Sternberg
2.Reason for the notification
a)Position / statusHead of US Commercial - PDMR
b)Initial notification / amendmentInitial notification
3.Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor
a)NameShire plc
b)LEI54930005LQRLI2UXRQ59
4.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrumentShire plc American Depositary Shares (“ADSs”)
Identification codeISIN: US82481R1068
b)Nature of the transactionAutomatic exercise of option over notional ADSs granted under the Shire Global Employee Stock Purchase Plan on November 1, 2017, and consequent receipt of ADSs.
c)Price(s) and volume(s)Price(s)Volume(s)
$125.4999
d)Aggregated information

- Aggregated volume

- Price
N/A (single transaction)
e)Date of the transactionOctober 31, 2018
f)Place of the transactionN/A


1.Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”)
a)NameKim Stratton
2.Reason for the notification
a)Position / statusHead of International Commercial - PDMR
b)Initial notification / amendmentInitial notification
3.Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor
a)NameShire plc
b)LEI54930005LQRLI2UXRQ59
4.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrumentShire plc Ordinary Shares of 5 pence each (“Ordinary Shares”)

 
Identification codeISIN: JE00B2QKY057
b)Nature of the transactionAutomatic exercise of option over notional Ordinary Shares granted under the Shire Global Employee Stock Purchase Plan on November 1, 2017, and consequent receipt of Ordinary Shares.

 

(Details of related disposal of Ordinary Shares are referenced in section 5. below.)
c)Price(s) and volume(s)Price(s)Volume(s)
£  31.63 297
d)Aggregated information

- Aggregated volume

- Price
N/A (single transaction)
e)Date of the transactionOctober 31, 2018
f)Place of the transactionN/A
5.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrumentShire plc Ordinary Shares of 5 pence each (“Ordinary Shares”)

 

 
Identification codeISIN: JE00B2QKY057
b)Nature of the transactionAutomatic disposal of Ordinary Shares related to the automatic option exercise referenced in section 4. above. The proceeds of this disposal were used to satisfy personal tax liabilities arising from the option exercise.
c)Price(s) and volume(s)Price(s)Volume(s)
£46.522429
d)Aggregated information

- Aggregated volume

- Price
N/A (single transaction)
e)Date of the transactionOctober 31, 2018
f)Place of the transactionLondon Stock Exchange (XLON)


1.Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”)
a)NameMatt Walker
2.Reason for the notification
a)Position / statusHead of Technical Operations - PDMR
b)Initial notification / amendmentInitial notification
3.Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor
a)NameShire plc
b)LEI54930005LQRLI2UXRQ59
4.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrumentShire plc American Depositary Shares (“ADSs”)
Identification codeISIN: US82481R1068
b)Nature of the transactionAutomatic exercise of option over notional ADSs granted under the Shire Global Employee Stock Purchase Plan on November 1, 2017, and consequent receipt of ADSs.
c)Price(s) and volume(s)Price(s)Volume(s)
$125.4999
d)Aggregated information

- Aggregated volume

- Price
N/A (single transaction)
e)Date of the transactionOctober 31, 2018
f)Place of the transactionN/A

Sarah Rixon
Senior Company Secretarial Assistant

For further information please contact:

Investor Relations  
Christoph Brackmannchristoph.brackmann@shire.com+41 41 288 41 29
Sun Kimsun.kim@shire.com+1 617 588 8175
Scott Burrowsscott.burrows@shire.com+41 41 288 4195
   
Media  
Katie Joyce

 
kjoyceshire.com +1 781 482 2779
   

NOTES TO EDITORS

About Shire

Shire is the global biotechnology leader serving patients with rare diseases and specialized conditions. We seek to push boundaries through discovering and delivering new possibilities for patient communities who often have few or no other champions. Relentlessly on the edge of what’s next, we are serial innovators with a diverse pipeline offering fresh thinking and new hope. Serving patients and partnering with healthcare communities in over 100 countries, we strive to be part of the entire patient journey to enable earlier diagnosis, raise standards of care, accelerate access to treatment, and support patients. Our diverse portfolio of therapeutic areas includes Immunology, Hematology, Genetic Diseases, Neuroscience, Internal Medicine, and Ophthalmics.
 
Championing patients is our call to action - it brings the opportunity - and responsibility - to change people’s lives.

www.shire.com

© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.